Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

NICE approves allergy asthma injection

  • Comment

NICE has approved omalizumab (Xolair), a fortnightly injection for the treatment of allergic asthma in adults and children over 12 years, which data suggests could halve acute asthma exacerbations.


The institute said it should only be used if the asthma was still severe and unstable despite efforts to control it with other therapies, and should be used alongside current asthma medications. If symptoms are not controlled after 16 weeks, treatment should be stopped.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs